Research on integrated control protocols for influenza
- Conditions
- Influenza AJ10.001
- Registration Number
- ITMCTR2024000109
- Lead Sponsor
- Guang'anmen Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Compliance with western medical diagnosis of influenza A;
(2) Comply with the Chinese medicine diagnostic criteria for the syndrome of surface cold and internal heat;
(3) Age between 18-70 years old, gender is not limited;
4) Onset time = 48h;
(5) Body temperature =37.3?;
(6) Willing to participate in the study and sign an informed consent form.
1) Patients with severe influenza, critically ill influenza, or influenza viral pneumonia;
2) Combined bacterial, fungal, or other respiratory viral (e.g., respiratory syncytial virus, rhinovirus, etc.) infection
Patients;
(3) Patients with combined serious primary diseases of the lung, heart, brain, liver, kidney and other systems;
(4) Pregnant or breastfeeding women and women who plan to become pregnant during the study period;
(5) Known allergy to the components of the research product, or allergy;
6) Patients with psychiatric abnormalities who cannot cooperate with the study, or patients with epilepsy with unstable conditions;
7) Those who have been treated with anti-viral medications prior to the visit;
(8) Those who have other inappropriate drug test observation, or cannot cooperate with the treatment, and it is difficult to make a definitive evaluation of the effectiveness and safety of the drug.
The patients who are not able to cooperate with the treatment, and it is difficult to make a definite evaluation of the effectiveness and safety of the drugs.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method